Patient-derived breast tumor xenografts facilitating personalized cancer therapy

by Landis, Melissa D, Lehmann, Brian D, Pietenpol, Jennifer A, Chang, Jenny C
Published 2013

Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells

by Taylor, Jackson R., Lehmann, Brian D., Chappell, William H., Abrams, Stephen L., Steelman, Linda S., McCubrey, McCubrey
Published 2011

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

by Chen, Xi, Li, Jiang, Gray, William H., Lehmann, Brian D., Bauer, Joshua A., Shyr, Yu, Pietenpol, Jennifer A.
Published 2012

Detection of internal exon deletion with exon Del

by Guo, Yan, Zhao, Shilin, Lehmann, Brian D, Sheng, Quanhu, Shaver, Timothy M, Stricker, Thomas P, Pietenpol, Jennifer A, Shyr, Yu
Published 2014

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

by Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Published 2016

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

by Lehmann, Brian D., Jovanović, Bojana, Chen, Xi, Estrada, Monica V., Johnson, Kimberly N., Shyr, Yu, Moses, Harold L., Sanders, Melinda E., Pietenpol, Jennifer A.
Published 2016

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

by Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Published 2016

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

by Mohni, Kareem N., Thompson, Petria S., Luzwick, Jessica W., Glick, Gloria G., Pendleton, Christopher S., Lehmann, Brian D., Pietenpol, Jennifer A., Cortez, David
Published 2015

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

by Jovanović, Bojana, Beeler, J Scott, Pickup, Michael W, Chytil, Anna, Gorska, Agnieszka E, Ashby, William J, Lehmann, Brian D, Zijlstra, Andries, Pietenpol, Jennifer A, Moses, Harold L
Published 2014

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer

by Wilson, Andrew J., Fadare, Oluwole, Beeghly-Fadiel, Alicia, Son, Deok-Soo, Liu, Qi, Zhao, Shilin, Saskowski, Jeanette, Uddin, Md. Jashim, Daniel, Cristina, Crews, Brenda, Lehmann, Brian D., Pietenpol, Jennifer A., Crispens, Marta A., Marnett, Lawrence J., Khabele, Dineo
Published 2015

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

by Lehmann, Brian D, Bauer, Joshua A, Schafer, Johanna M, Pendleton, Christopher S, Tang, Luojia, Johnson, Kimberly C, Chen, Xi, Balko, Justin M, Gómez, Henry, Arteaga, Carlos L, Mills, Gordon B, Sanders, Melinda E, Pietenpol, Jennifer A
Published 2014